key: cord-0866213-04vaizel
authors: Blair, Robert V.; Vaccari, Monica; Doyle-Meyers, Lara A.; Roy, Chad J; Russell-Lodrigue, Kasi; Fahlberg, Marissa; Monjure, Chris J.; Beddingfield, Brandon; Plante, Kenneth S.; Plante, Jessica A.; Weaver, Scott C.; Qin, Xuebin; Midkiff, Cecily C.; Lehmicke, Gabrielle; Golden, Nadia; Threeton, Breanna; Penney, Toni; Allers, Carolina; Barnes, Mary B; Pattison, Melissa; Datta, Prasun K; Maness, Nicholas J; Birnbaum, Angela; Fischer, Tracy; Bohm, Rudolf P.; Rappaport, Jay
title: “Acute Respiratory Distress and Cytokine Storm in Aged, SARS-CoV-2 Infected African Green Monkeys, but not in Rhesus Macaques”
date: 2020-08-11
journal: bioRxiv
DOI: 10.1101/2020.06.18.157933
sha: b20fb1a6234ec72c24f086bdfff18625dbd72042
doc_id: 866213
cord_uid: 04vaizel

SARS-CoV-2 induces a wide range of disease severity ranging from asymptomatic infection, to a life-threating illness, particularly in the elderly and persons with comorbid conditions. Among those persons with serious COVID-19 disease, acute respiratory distress syndrome (ARDS) is a common and often fatal presentation. Animal models of SARS-CoV-2 infection that manifest severe disease are needed to investigate the pathogenesis of COVID-19 induced ARDS and evaluate therapeutic strategies. Here we report ARDS in two aged African green monkeys (AGMs) infected with SARS-CoV-2 that demonstrated pathological lesions and disease similar to severe COVID-19 in humans. We also report a comparatively mild COVID-19 phenotype characterized by minor clinical, radiographic and histopathologic changes in the two surviving, aged AGMs and four rhesus macaques (RMs) infected with SARS-CoV-2. We found dramatic increases in circulating cytokines in three of four infected, aged AGMs but not in infected RMs. All of the AGMs showed increased levels of plasma IL-6 compared to baseline, a predictive marker and presumptive therapeutic target in humans infected with SARS-CoV-2 infection. Together, our results show that both RM and AGM are capable of modeling SARS-CoV-2 infection and suggest that aged AGMs may be useful for modeling severe disease manifestations including ARDS.

Animal models have been used extensively during previous outbreaks of SARS-CoV (7-11) and 77 to model disease progression and to test vaccines and therapeutics. Nonhuman 78 primates (NHPs) are ideally suited to model respiratory human viral infections primarily because 79 of the similarities to human respiratory anatomy and immunologic responses when compared to 80 other animal species. Several NHP species have already been successfully employed to model 81 pathogenesis (15) (16) (17) (18) (19) and test vaccine candidates (20-23) for SARS-CoV-2. These prior studies 82 have shown NHPs are susceptible to infection and develop mild to moderate disease, but none 83 has been able to recapitulate the rapid clinical deterioration seen in people with severe disease 84 and ARDS. NHP models capable of recapitulating the entire spectrum of SARS-CoV-2 85 manifestations, from mild to severe disease, are urgently needed to not only test the efficacy of 86 vaccines and medical countermeasures that are currently being developed in response to 19, but to also investigate the pathogenesis and virus-host interactions of SARS-CoV-2. Age is a 88 well-established risk factor for severe disease and death in humans infected with SARS-CoV-2 89 (2,24,25), and therefore we challenged older RM and AGMs with SARS-CoV-2 to see if a 90 similar more severe disease phenotype was observed in aged cohorts.

Here we report the sudden and rapid health deterioration of two out of four aged AGMs 97 Four, aged, AGMs and four RM, thirteen to fifteen years of age, were exposed by two routes to 98 SARS-CoV-2 isolate USA-WA1/2020. Four animals were exposed via small particle aerosol 99 (AGM1, AGM4, RM3, RM4) and received an inhaled dose of approximately 2x10 3 TCID50. 100 Four animals were exposed via multiple route installation (AGM 2, AGM3, RM1, RM2) 101 including conjunctival, intratracheal, oral, and intranasal exposure resulting in a cumulative dose 102 of 3.61x10 6 PFU (Supplemental Table 1 ). SARS-CoV-2 RNA was detectable in swabs obtained 103 from mucosal sites in all eight animals. For AGMs the viral RNA peaked between 3-and 7 days 104 post inoculation (DPI) and persisted throughout the course of the study in pharyngeal and nasal 105 swabs as well as bronchial brush samples (Figure 1 ). In RMs, viral RNA peaked earlier between 106 1-and 5 DPI. After peak, viral RNA loads in RM gradually declined to undetectable levels at all 107 sites by 21 DPI, except in nasal swabs which had detectable virus at necropsy in two out of four 108 RM. The highest levels of viral RNA were detected in the pharynx and nasal cavity with peaks 109 at 10 7 -10 11 and 10 8 -10 9 in AGM and 10 6 -10 8 and 10 5 -10 11 copies per swab in RM, respectively. 110 Rectal swabs contained high viral RNA loads similar to reports in humans (27, 28) ; however, 111 with dissimilar kinetics in AGMs relative to virus detected in other sites, peaking between 7-and 112 14 DPI. Viral RNA was also detected in vaginal swabs of the two female AGMs in contrast to 113 reports in human subjects (29). Despite the 3 log difference in exposure dose, in comparing 114 aerosol and mulit-route viral challenge, no significant difference was observed in the viral RNA 115 loads or kinetics.

After SARS-CoV-2 exposure, animals were followed up to four weeks post-infection with 118 regular clinical assessment that included physical exam, pulse oximetry, and plethysmography.

Clinical findings during the first 6 DPI included mild transient changes in SpO2 and appetite with 120 one RM3 exhibiting mild intermittent fever (Supplemental Figure 1 ). At 7 DPI all animals 121 underwent a complete physical evaluation and an extensive sample collection protocol including 122 fluid (urine, CSF, BAL, and vaginal and rectal weks), stool, swab (buccal, nasal, and 123 pharyngeal), and bronchial brush collection, no remarkable findings were noted. That afternoon 124 (7 DPI), AGM1 developed mild tachypnea that progressed to severe respiratory distress in less 125 than 24 hours. On the morning of the 8 th DPI, the animal was discovered recumbent and exam 126 findings included dyspnea, tachypnea, hypothermia, and an SpO2 of 77% under oxygen 127 supplementation (Supplemental Figure 1) Thoracic radiographs for AGM1 and AGM2 revealed a diffuse alveolar pattern throughout the 136 right lung fields and a lobar sign in the caudal dorsal lung field. In AGM2 the left caudal lung 137 lobe also contained a mild alveolar pattern. These findings were in stark contrast to the 138 radiographs from the day before highlighting the rapid disease progression (Figure 2 ). The 139 radiographic presentation in severe human COVID-19 is similar and characterized by bilateral, 140 peripheral, ill-defined ground glass opacifications that more frequently involve the right lower 141 lobe (30). No radiographic changes were noted in AGM3 and AGM4. RM1 developed mild to 142 moderate radiographic opacities in the right caudal lung lobe by 11 DPI which gradually 143 resolved over time. RM2 revealed a small area of increased opacity in the ventral lung field at 11 144 DPI which was not observed on subsequent radiographs.

Rapid disease progression in AGM1 and AGM2 was associated with an elevated WBC, a mature 146 neutrophilia and a normal lymphocyte count that resulted in an elevated neutrophil-to-147 lymphocyte ratio (NLR) (Supplemental Figure 2 ). These changes were not observed in the other 148 two AGM or in four RM. Mild lymphopenia was observed at acute time points in RM1-3; 149 however, in the absence of neutrophilia, the NLR was only mildly elevated (<4) in these animals. hyperglobulinemia. Elevated NLR has been identified as an independent risk factor for mortality 156 in hospitalized patients with SARS-CoV-2, and increased NLR significantly correlated with elevations in AST, glucose, BUN, and creatinine in these patients (31). The constellation of 158 hematologic changes in AGM1 and AGM2 is therefore similar to the changes observed in human 159 COVID-19 patients with increased NLR; however in humans, increased NLR is often associated 160 with lymphopenia (32) which was not observed in these two animals.

Due to their rapidly declining clinical condition, AGM1 and AGM2 were euthanized at 8 and 22 162 DPI, respectively. All remaining animals (2 AGM and 4 RM) were euthanized at the study 163 endpoint between three-and four-weeks post infection. A complete necropsy was performed on 164 all animals.

Increased plasma cytokines in two AGMs with, and one without, ARDS 166 Increased plasma cytokines has been observed in a subgroup of patients with severe COVID-19 167 pneumonia (33). In these patients the disease progresses rapidly, and mortality is high. A panel Table 2 ). was not available for the AGMs as it was for the RM that were born at TNPRC. All of the AGMs 298 used in the study were found to be in excellent health upon importation, underwent an 299 unremarkable 90-day quarantine period, and were housed at the TNPRC for 10 months prior to 300 use. All animals were examined, and screened for viral, bacterial, and parasitic infections prior to 301 inclusion as subjects on this study. Although the animals were deemed clinically healthy at the 302 time of initiation of the study, there may have been historical factors that predisposed them to 303 enhanced COVID-19 disease.

Our findings in AGMs differ from previous reports through the identification of a severe 305 phenotype that exhibited rapid clinical decline, acute respiratory distress, and cytokine release 306 concurrently. Major differences in study design may account for the discrepancy between our 307 results and those of prior studies utilizing AGMs including the age of the animals and the strain 308 of virus that was used. Apart from the severe phenotype observed in two of the animals, our This study demonstrates that following exposure to SARS-CoV-2 aged AGMs develop a 323 spectrum of disease, from mild to severe COVID-19, which in some cases progress to ARDS.

The cytokine expression profile in the two animals that developed ARDS is similar to that seen 325 in the severe human disease phenotype. Animal models play a crucial role in elucidating the processing. All right lung lobes were infused and stored in fixative for microscopic evaluation.

The remainder of the necropsy was performed routinely with collection of tissues in media, 367 fixative, or fresh.

Tissue samples were fixed in Z-fix (Anatech), embedded in paraffin and 5 um thick sections 369 were cut, adhered to charged glass slides and stained routinely. Tissue examined microscopically 370 included: nasal turbinate, nasopharynx, trachea, carotid artery, aorta, heart, tongue, salivary 371 gland, esophagus, stomach, duodenum, jejunum, pancreas, ileocecal junction, colon (ascending, 372 transverse, descending), rectum, liver, gall bladder, spleen, kidney, urinary bladder, thyroid, 373 pituitary, adrenal, lymph nodes (bronchial, mesenteric, submandibular, cervical, axillary, 374 inguinal, bronchial), tonsils (palatine, lingual), brain (olfactory bulb, frontal cortex, temporal 375 cortex, parietal cortex, occipital cortex, basal ganglia, cerebellum, brainstem), spinal cord 376 (cervical), and reproductive system (ovary, uterus, vagina or testis, seminal vesicle, prostate).

All slides were scanned on a Zeiss Axio Scan.Z1 digital slide scanner. Images and figures were 378 made using HALO software (Indica Labs).

Pulmonary pathology was scored using two separate random forest tissue segmentation 381 algorithms trained by a veterinary pathologist to recognize fibrin and edema and cellular 382 inflammation using HALO software. Tissue sections from each of the right lung lobes was 383 segmented using the trained algorithms to quantify the percentage of tissue effected by fibrin and 384 edema or cellular inflammation. The percentage of inflammation was converted to a pathology 385 score based on the scoring system in the table below. The "Histopathology score" was made by 386 summating the fibrin and edema and cellular inflammation scores for each lobe. during the run, whichever was smaller. Polar coordinate plots were generated using the 'ggplot2' 450 package in R(47)(46), using the same normalized data shown in the heatmap. Scatterplots were 451 drawn using raw data points and display Pearson's correlation coefficients.

Detection of binding IgG antibody in plasma 454 Serum samples collected at preinfection and at necropsy were tested for binding IgG antibodies 455 against SARS-CoV-2 S1/S2 proteins using an ELISA kit from XpressBio (cat# SP864C). The the staining. GL contributed to study design, provided administrative support, and aided with 513 sample processing and archiving. NG contributed to study design, study coordination, sample 514 processing, and SOP development. BT, TP contributed to sample processing including RT-qPCR, fluids, swabs, and necropsy tissues. CA analysis and interpretation of antibody data and 516 revision of manuscript. MBB analysis and interpretation of antibody data. MP performed 517 antibody testing. PKD processed and analyzed viral load data and contributed to the writing of 518 the manuscript. NJM contributed to study design, analyzed data and contributed to writing the 519 manuscript. AB reviewed and optimized all technical SOPs and was responsible for safety of this 520 study. TF contributed to study design, planning, and writing of the manuscript. RPB contributed 521 to study design, analysis of clinical and imaging results, and writing the manuscript.

JR conceived, designed, and supported study, analyzed data, contributed to writing the 523 manuscript.

Acknowledgements 525 We would like to acknowledge Natalie Thornburg at the NCIRD for her help acquiring and 526 characterizing the viral stock used in this infection study. We would like to thank the NIH for 527 supporting this work through the TNPRC base grant (P51 OD011104 59) and grant R24 528 AI120942 to SCW. We would like to thank FastGrant for their funding support to TF. 

Characteristics of and Important Lessons From the Coronavirus Disease 532 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese 533 Center for Disease Control and Prevention

Clinical course and outcomes of critically ill patients with SARS-CoV-2 535 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Temporal changes in cytokine/chemokine 538 profiles and pulmonary involvement in severe acute respiratory syndrome

Pathogenic human coronavirus infections: causes and 541 consequences of cytokine storm and immunopathology

The Role of Cytokines including Interleukin-6 544 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease

Coronavirus pathogenesis

Cynomolgus macaque as an animal model for severe acute 548 respiratory syndrome

Distinct severe acute respiratory syndrome 550 coronavirus-induced acute lung injury pathways in two different nonhuman primate species

Severe acute respiratory syndrome-coronavirus infection 553 in aged nonhuman primates is associated with modulated pulmonary and systemic immune 554 responses

Pneumonitis and multi-organ system disease in 556 common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-557 associated coronavirus. The American journal of pathology

SARS-CoV-2 pandemic and research gaps: 559 Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

MERS coronavirus induces apoptosis in kidney and lung by 562 upregulating Smad7 and FGF2

An Acute Immune Response to Middle East Respiratory 564

Syndrome Coronavirus Replication Contributes to Viral Pathogenicity. The American journal of 565 pathology

Prophylactic and therapeutic remdesivir (GS-5734) 567 treatment in the rhesus macaque model of MERS-CoV infection. Proceedings of the National 568 Academy of Sciences of the United States of America

Establishment of an African green monkey model for 570 COVID-19. bioRxiv

SARS-CoV-2 infection leads to acute infection with dynamic cellular and 572 inflammatory flux in the lung that varies across nonhuman primate species

Respiratory disease in rhesus macaques 574 inoculated with SARS-CoV-2

SARS-CoV-2 infection of African green monkeys results in mild respiratory 576 disease discernible by PET/CT imaging and prolonged shedding of infectious virus from both 577 respiratory and gastrointestinal tracts

Comparative pathogenesis of COVID-19, MERS, and SARS in a 579 nonhuman primate model

Development of an inactivated vaccine candidate for SARS-CoV-2. 583 Science

DNA vaccine protection against SARS-CoV-2 in rhesus 585 macaques

An alphavirus-derived replicon RNA vaccine 587 induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. 588 Science translational medicine

Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China 590 and the Republic of Korea

Epidemiological, clinical characteristics of cases of SARS-CoV-2 593 infection with abnormal imaging findings

Prevalence and severity of corona virus disease 2019 (COVID-19): A 595 systematic review and meta-analysis

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Temporal profiles of viral load in posterior oropharyngeal 599 saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational 600 cohort study

SARS-CoV-2 is not detectable in the vaginal fluid of women with 602 severe COVID-19 infection. Clinical infectious diseases : an official publication of the Infectious 603 Diseases Society of America

Radiological findings from 81 patients with COVID-19 pneumonia

China: a descriptive study

Neutrophil-to-lymphocyte ratio as an independent risk factor for 607 mortality in hospitalized patients with COVID-19

Clinical features of patients infected with

The Berlin definition of ARDS: an expanded rationale, 613 justification, and supplementary material

Definition of ALI/ARDS

Rescue of rhesus macaques from the lethality of 616 aerosolized ricin toxin

Animal models of acute lung injury

Local inflammatory responses following bronchial endotoxin 620 instillation in humans

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated 622

High Prevalence of Obesity in Severe Acute Respiratory 625

Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver 626 Spring)

Sex-and Gender-specific Observations and Implications for COVID-19

Gender Differences in Patients With COVID-19: Focus on Severity and 630 Mortality

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient 632 with Coronavirus Disease, United States. Emerging infectious diseases

The automated bioaerosol exposure system: preclinical platform 634 development and a respiratory dosimetry application with nonhuman primates

pheatmap: Pretty Heatmaps. R package version 1012

R: A language and environment for statistical computing. R Foundation for Statistical 638 Computing

Elegant Graphics for Data Analysis

All animals (4 African 644 green monkeys and 4 rhesus macaques) had detectable virus at mucosal sites. No significant 645 differences were noted in viral load between species and route of exposure (Mann-Whitney U 646 test)

Radiographic changes in SARS-CoV-2 infected AGMs with ARDS. Radiographs 653 the day prior (A,C) and at the time of necropsy (B,D) in AGM1 (A,B) and AGM2 (C,D) 654 showing the rapid development of alveolar lung opacities within the lungs of both animals

Heat map (A) showing changes in the levels of ten cytokines in 658 plasma at week 1 and necropsy with respect to the baseline in AGMs and RM. Data are 659 normalized (log2). B) Levels of IFNg (pg/ml) in plasma at baseline

Column represents mean, error bars are SEM. C) Association between IFNg levels at week 1 and 661 viral load in bronchiolar brushes

Gross pathologic findings of AGM with ARDS. Both AGM1

D) have extensive consolidation of the right caudal lung lobe (B,D; arrows) with lesser 666 involvement of the right middle and cranial lung lobes. The left lung of AGM1 (A) fails to 667 collapse. The left lung of AGM2 (C) does not have gross abnormalities

Histopathology and fluorescent immunohistochemistry in AGM1. (A) The right 671 lower lung lobe is filled with fibrin and edema with areas of hemorrhage and necrosis (arrows)

Bar = 5 mm. (B) Alveoli are variably lined by hyaline membranes (arrows) and type II 673 pneumocytes (arrowheads)

Bar = 100 um. (C) Rare multinucleated syncytia (arrow) are 674 scattered throughout the affected lungs; Bar = 50 um. (D) Fluorescent immunohistochemistry for 675

COV-2 nucleoprotein (green, arrows) and ACE2 (red) identified low numbers of CoV-2 positive 676 cells within the affected lung lobes; Bar = 100 um. White: DAPI/nuclei

Supplemental Figure 1. Clinical parameters of African green monkeys and rhesus 681 macaques following exposure to SARS-CoV-2. There were no significant differences in 682 clinical parameters leading up to development of ARDS in the two animals that progressed

Progression to ARDS was associated with spike in physical exam scores, respiratory rate, and a 684 dramatic decline in SPO2. Neither weight loss nor fever was associated with SARS-CoV-2 685 exposure in any of the 8 animals. Circles: aerosol exposure; Squares: multiroute exposure; Gray: 686 Rhesus macaques; Color: AGM by outcome

Supplemental Figure 2. Hematologic and chemistry abnormalities in AGMs with ARDS

The animals that progressed to ARDS (red) only showed hematologic derangements at the 692 terminal timepoint after the onset of respiratory distress. Circles: aerosol exposure; Squares: 693 multiroute exposure; Gray: Rhesus macaques; Color: AGM by outcome

Purple: increased cytokines without ARDS; Blue: no cytokine increase or ARDS

AGMs exhibited higher levels of IFNg at one-week post infection 699 compared to rhesus macaques with the two animals (AGM1 and AGM2, red) that progressed 700 showing the highest elevation

IL-13, and IL-4. AGM4 (purple) had a similar cytokine profile except with little elevation in IL-702

AGM3 (blue) had elevated IL-10 one-week post infection and is notable for having the lowest 703 pathology scores of the four AGM. RM showed modest changes in serum cytokines at one-week 704 post infection and at necropsy. Circles: aerosol exposure; Squares: multiroute exposure; Gray: 705 Rhesus macaques; Color: AGM by outcome

Kinetics of binding antibody responses in SARS-CoV-2 infected 710

Circles: aerosol exposure; Squares: multiroute 711 exposure; Gray: Rhesus macaques; Color: AGM by outcome. Red: developed ARDS; Purple: 712 increased cytokines without ARDS; Blue: no cytokine increase or ARDS

Supplemental Figure 5. Gross pathology of the right lung lobes of SARS-CoV-2 infected 716

E-H, Rhesus macaques. RM1 720 (E) has a scar along the caudodorsal margin of the right lower lobe surrounded by acute 721 hemorrhage. RM2 (F) has red mottling of the dorsal margin of the right lower and anterior lung 722 lobes

Representative images of the 728 histopathology of the right caudal lung lobe from AGM (top row, left to right AGM1-4) and RM 729 (bottom row

Whole slide 732 images of tissue sections from each lung lobe were analyzed for fibrin/edema and cellular 733 inflammation using HALO's Tissue Classifier module

Middle row: representative images of cellular inflammation scores 0-2 735 and 4. Graphs illustrate the score of inflammation in each of the right lung lobes

Histopathologic Score is the aggregate score of Fibrin/Edema and Cellular Inflammation

Supplemental Table 1. Animal information including species, source, route of exposure, 740 and demographic information from each animal in the study

Histopathologic changes including 744 localization of inflammation in the lung, morphologic diagnoses, and their semiquantitative 745 severity assigned by a pathologist as follows: -: absent; +: minimal

++++: severe. Squamous metaplasia refers to respiratory epithelium of the nasal turbinates